Comparing COVID-19 To The 2019 US-China Trade War

U.S. stocks have taken a beating in recent weeks on growing concerns about the negative economic impact of a global outbreak of the COVID-19 coronavirus. DataTrek Research co-founder Nicholas Colas compared the negative market impact of the coronavirus outbreak to the positive impact of January’s phase one trade deal between the U.S. and China.

“Think of the market action around COVID-19 as an unwind of the market’s Q4 2019 confidence about renewed global growth,” Colas said.

Rate Expectations

He pointed out that from early September 2019 to the beginning of 2020, the spread between 3-month and 10-year Treasuries increased from -0.51% to +0.37%. Unfortunately, coronavirus fears have inverted that spread once again, which is now down to -0.13%. Colas said the current spread is roughly the midpoint of the fourth-quarter 2019 range prior to the trade deal.

The futures market has also adjusted its interest rate expectations significantly in recent months. Prior to the trade deal, the market was pricing in a 1% to 1.25% fed funds target range for June 2020. By the end of the year, the market was pricing in no change to interest rates. Today, the futures market is pricing in an 87.6% chance of at least one rate cut by June and a 95.5% chance of a cut by the end of the year.

Dow Plummets 2K Points In 2 Days: Here's What The Pros Think

Growth Concerns

Colas said investors went from being concerned about global economic growth in 2020 due to the trade war to having expectations that growth would be fine once a phase one deal was reached. Investors are now back in doubt of the economic outlook due to the outbreak, however, and Colas said markets may not have fully reset just yet.

“If one assumes that the global economic effects of COVID-19 are a wash with the US and China signing a phase one trade deal (the cause of Q4’s global equity rally), then US large cap stocks still have 5% further downside since Q3 2019’s S&P 500 close was 2977,” he said.

Since the end of the third quarter of 2019, here’s a look at how some popular ETFs have performed overall:

  • SPDR S&P 500 ETF Trust SPY is up 6.9%.
  • iShares MSCI Emerging Markets Indx EEM is up 3%.
  • iShares FTSE/Xinhua China 25 Index FXI is up 2.8%.

Benzinga’s Take

Obviously, the negative impact of the coronavirus will not perfectly offset the positive impact of the trade deal, and that’s not the point Colas is making. If anything, the strength of the market in the fourth quarter of 2019 and into February of 2020 is an indication of the type of rebound investors could potentially expect if the outbreak dies down or is contained at some point.

Do you agree with this take? Email feedback@benzinga.com with your thoughts.

Posted In: Analyst ColorBondsEmerging MarketsFuturesTop StoriesMarketsAnalyst RatingsCoronavirusCovid-19DataTrek ResearchNicholas Colastrade war
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...